Clinical study on the safety and efficacy of conversion from selegiline to rasagiline in patients with Parkinson's disease and sleep disorders. Prospective, open, explorative study on conversion of selegiline to rasagiline. [Klinische Untersuchung zur Verträglichkeit und Wirksamkeit nach Umstellung von Selegilin auf Rasagilin bei Patienten mit Morbus Parkinson und Schlafstörungen. Prospektive, offene, explorative Studie mit Umstellung von Selegilin auf Rasagilin.]

Trial Profile

Clinical study on the safety and efficacy of conversion from selegiline to rasagiline in patients with Parkinson's disease and sleep disorders. Prospective, open, explorative study on conversion of selegiline to rasagiline. [Klinische Untersuchung zur Verträglichkeit und Wirksamkeit nach Umstellung von Selegilin auf Rasagilin bei Patienten mit Morbus Parkinson und Schlafstörungen. Prospektive, offene, explorative Studie mit Umstellung von Selegilin auf Rasagilin.]

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Jan 2014

At a glance

  • Drugs Rasagiline (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jan 2014 Planned initiation date changed to 7 Jul 2008 as reported in European Clinical Trials Database.
    • 18 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top